Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;36(6):1217-1237.
doi: 10.1016/j.hoc.2022.07.014.

The Cardiopulmonary Complications of Sickle Cell Disease

Ankit A Desai  1 , Roberto F Machado  2 , Robyn T Cohen  3
Affiliations
Review

The Cardiopulmonary Complications of Sickle Cell Disease

Ankit A Desai et al. Hematol Oncol Clin North Am. 2022 Dec.

Abstract

Sickle cell disease (SCD) is a genetic hemoglobinopathy associated with extensive morbidity and early mortality. While there have been recent improvements in available disease-modifying therapies for SCD, cardiopulmonary complications remain a major risk factor for death in this population. We provide an overview of current knowledge regarding several of the major acute and chronic cardiopulmonary complications in SCD, including: acute chest syndrome, airway disease, lung function abnormalities, nocturnal hypoxemia and sleep disordered breathing, pulmonary vascular disease, and sickle cell cardiomyopathy.

Keywords: Acute chest syndrome; Lung function; Pulmonary hypertension; Sickle cell cardiomyopathy; Sickle cell disease; Sleep-disordered breathing.

PubMed Disclaimer

Conflict of interest statement

Disclosure A.A. Desai: R01HL136603. R.F. Machado: NIH (R01HL127342); (R01HL158108); and (R01HL111656). R.T. Cohen: has no commercial or financial conflicts of interests.

Figures

Fig. 1.
Fig. 1.
Oxyhemoglobin dissociation curve. The rightward shift, as seen in SCD, indicates that oxyhemoglobin saturation at a given arterial oxygen pressure is lower in patients with SCD because of decreased oxygen affinity of HbS, increased 2,3 diphosphoglycerate (2,3 DPG) in sickled erythrocytes, hypoventilation due to pain or opioid use, and as an adaptation to severe anemia to prevent tissue hypoxia. (From Caboot JB, Allen JL. Hypoxemia in sickle cell disease: significance and management. Paediatr Respir Rev. 2014 Mar;15(1):17–23. https://doi.org/10.1016/j.prrv.2013.12.004. Epub 2013 Dec 21. PMID: 24461342.)
Fig. 2.
Fig. 2.
Overview of causes of PH in SCD. PH in SCD patients may be due to multiple different etiologies and often with multiple underlying causes. An overview of the different etiologies, their hemodynamics, and therapeutic options are listed. BPA, balloon pulmonary angioplasty; CTEPH, chronic thromboembolic PH; mPAP, mean pulmonary artery pressure; OSA, obstructive sleep apnea; PAOP, pulmonary artery occlusion pressure; PVR, pulmonary vascular resistance. (From Prohaska CC, Machado RF. The different facets of sickle cell disease-related pulmonary hypertension. Curr Opin Pulm Med. Sep 1 2021;27(5):319–328.)
See this image and copyright information in PMC

References

    1. Liem RI, Lanzkron S, Coates TC, et al. American society of hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv 2019;3(23):3867–97. - PMC - PubMed
    1. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312(10):1033–48. - PubMed
    1. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342(25):1855–65. - PubMed
    1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330(23):1639–44. - PubMed
    1. Powars D, Weidman JA, Odom-Maryon T, et al. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988; 67(1):66–76. - PubMed

MeSH terms